Skip to main content
SpringerLink
Log in

Beta blockers, ACEI/ARB therapy prevent LVEF decline from trastuzumab/anthracycline therapy

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lewinter C, et al. A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. European Heart Journal : 24 Dec 2021. Available from: URL: http://doi.org/10.1093/eurheartj/ehab843

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beta blockers, ACEI/ARB therapy prevent LVEF decline from trastuzumab/anthracycline therapy. Reactions Weekly 1888, 9 (2022). https://doi.org/10.1007/s40278-022-08351-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-08351-8

Search

Navigation